---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-008931"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2022-04-11T23:59:59+00:00"
generated_at: "2026-06-26T08:11:39.025352+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Kurt Gustafson not seeking re-election at June 2022 annual meeting

## Summary
- Gustafson notified ChromaDex on April 5, 2022 of decision.
- He will remain on Board, Audit Committee, and Compensation Committee until June 2022 meeting.
- Departure is not due to any disagreement with the Company on operations, policies, or practices.

## SEC filing metadata
- accession: 0001628280-22-008931
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2022-04-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828022008931/0001628280-22-008931-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828022008931/cdxc-20220405.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-008931
- JSON: https://secwatch.observer/filing/0001628280-22-008931.json
- Plain text: https://secwatch.observer/filing/0001628280-22-008931.txt

## Key facts
- Executive change
  Kurt Gustafson departed as Director at Niagen Bioscience, Inc..
  - Action: not stand for re-election
  - Role: Director
  source text: On April 5, 2022, Kurt Gustafson notified ChromaDex Corporation (the “Company”) of his intention not to stand for re-election as director of Board of Directors of the Company (the “Board”) and as a member of the Audit Committee and Compensation Committee of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1386570/000162828022008931/0001628280-22-008931-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.